Quest Diagnostics share price today

(DGX)

Quest Diagnostics share price is $153.42 & ₹13,071.08 as on 25 Dec 2024, 2.30 'hrs' IST

$153.42

▲

0.48

(0.31%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Quest Diagnostics share price in Dollar and Rupees. Guide to invest in Quest Diagnostics from India. Also see the sentimental analysis on Indian investors investing in Quest Diagnostics. Get details on the Indian mutual funds that are investing in Quest Diagnostics. Get Analyst recommendations and forecasts along with all the Quest Diagnostics's financials.

Quest Diagnostics share price movements

Today's Low: $152.14
Today's High: $153.42
$153.42
0.83%
Downside
Day's Volatility :0.83%
Upside
0.0%
52 Weeks Low: $123.04
52 Weeks High: $165.32
$153.42
19.8%
Downside
52 Weeks Volatility :25.57%
Upside
7.2%

Quest Diagnostics Returns

Period	Quest Diagnostics Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-0.65%	-8.7%	0.0%
6 Months	11.71%	-5.0%	0.0%
1 Year	11.51%	3.2%	0.0%
3 Years	-9.41%	0.0%	-21.1%

Quest Diagnostics Key Statistics

in dollars & INR

Previous Close	$152.94
Open	$152.47
Today's High	$153.42
Today's Low	$152.14
Market Capitalization	$17.1B
Today's Volume	$205.9K
52 Week High	$165.32
52 Week Low	$123.04
Revenue TTM	$9.5B
EBITDA	$1.8B
Earnings Per Share (EPS)	$7.44
PE Ratio	20.62
Dividend Yield	1.96%
Profit Margin	8.82%
Quarterly Earnings Growth YOY	0.02%
Return On Equity TTM	13.22%

How to invest in Quest Diagnostics from India?

It is very easy for Indian residents to invest directly in Quest Diagnostics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Quest Diagnostics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Quest Diagnostics or DGX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Quest Diagnostics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Quest Diagnostics shares which would translate to 0.006 fractional shares of Quest Diagnostics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Quest Diagnostics, in just a few clicks!

Returns in Quest Diagnostics for Indian investors in Rupees

Investment Value

₹1,00,000

Quest Diagnostics investment value today

Current value as on today

₹1,13,939

Returns

₹13,939

(+13.94%)

Returns from Quest Diagnostics Stock

₹11,513 (+11.51%)

Dollar Returns

₹2,426 (+2.43%)

Indian investors sentiment towards Quest Diagnostics

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Quest Diagnostics on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 8% more investors are searching Quest Diagnostics in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Quest Diagnostics

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	957	-0.45	0.03%

Global Institutional Holdings in Quest Diagnostics

Vanguard Group Inc
12.52%
BlackRock Inc
9.01%
State Street Corp
4.72%
T. Rowe Price Associates, Inc.
3.45%
Victory Capital Management Inc.
3.10%
Geode Capital Management, LLC
2.34%

Analyst Recommendation on Quest Diagnostics

Hold

40%Buy

59%Hold

0%Sell

Based on 22 Wall street analysts offering stock ratings for Quest Diagnostics(by analysts ranked 0 to 5 stars)

Based on 22 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Quest Diagnostics

What analysts predicted

Upside of 10.78%

Current:

$153.42

Target:

$169.96

Insights on Quest Diagnostics

Price Movement
In the last 6 months, DGX stock has moved up by 10.9%
Increasing Revenue
Revenue is up for the last 4 quarters, 2.28B → 2.48B (in $), with an average increase of 2.8% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 229.0M → 226.0M (in $), with an average decrease of 1.3% per quarter

Quest Diagnostics Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$7.5B	↓ 2.31%
Net Income	$736.0M	↓ 4.66%
Net Profit Margin	9.77%	↓ 0.24%

	FY19	Y/Y Change
Revenue	$7.7B	↑ 2.59%
Net Income	$858.0M	↑ 16.58%
Net Profit Margin	11.11%	↑ 1.34%

	FY20	Y/Y Change
Revenue	$9.4B	↑ 22.15%
Net Income	$1.4B	↑ 66.78%
Net Profit Margin	15.16%	↑ 4.05%

	FY21	Y/Y Change
Revenue	$10.8B	↑ 14.32%
Net Income	$2.0B	↑ 39.41%
Net Profit Margin	18.49%	↑ 3.33%

	FY22	Y/Y Change
Revenue	$9.9B	↓ 8.39%
Net Income	$946.0M	↓ 52.58%
Net Profit Margin	9.57%	↓ 8.92%

	FY23	Y/Y Change
Revenue	$9.3B	↓ 6.38%
Net Income	$854.0M	↓ 9.73%
Net Profit Margin	9.23%	↓ 0.34%

	Q2 FY23	Q/Q Change
Revenue	$2.3B	↑ 0.3%
Net Income	$235.0M	↑ 16.34%
Net Profit Margin	10.05%	↑ 1.38%

	Q3 FY23	Q/Q Change
Revenue	$2.3B	↓ 1.84%
Net Income	$225.0M	↓ 4.26%
Net Profit Margin	9.8%	↓ 0.25%

	Q4 FY23	Q/Q Change
Revenue	$2.3B	↓ 0.31%
Net Income	$192.0M	↓ 14.67%
Net Profit Margin	8.39%	↓ 1.41%

	Q1 FY24	Q/Q Change
Revenue	$2.4B	↑ 3.41%
Net Income	$194.0M	↑ 1.04%
Net Profit Margin	8.2%	↓ 0.19%

	Q2 FY24	Q/Q Change
Revenue	$2.4B	↑ 1.31%
Net Income	$229.0M	↑ 18.04%
Net Profit Margin	9.55%	↑ 1.35%

	Q3 FY24	Q/Q Change
Revenue	$2.5B	↑ 3.8%
Net Income	$226.0M	↓ 1.31%
Net Profit Margin	9.08%	↓ 0.47%

	FY18	Y/Y Change
Profit	$2.6B	↓ 12.88%

	FY19	Y/Y Change
Profit	$2.7B	↑ 3.22%

	FY20	Y/Y Change
Profit	$3.6B	↑ 35.11%

	FY21	Y/Y Change
Profit	$4.2B	↑ 15.85%

	FY22	Y/Y Change
Profit	$3.4B	↓ 18.44%

	FY23	Y/Y Change
Profit	$3.1B	↓ 11.07%

	Q2 FY23	Q/Q Change
Profit	$792.0M	↑ 2.72%

	Q3 FY23	Q/Q Change
Profit	$754.0M	↓ 4.8%

	Q4 FY23	Q/Q Change
Profit	$740.0M	↓ 1.86%

	Q1 FY24	Q/Q Change
Profit	$755.0M	↑ 2.03%

	Q2 FY24	Q/Q Change
Profit	$776.0M	↑ 2.78%

	Q3 FY24	Q/Q Change
Profit	$811.0M	↑ 4.51%

	FY18	Y/Y Change
Operating Cash Flow	$1.2B	↑ 2.13%
Investing Cash Flow	$-801.0M	↓ 0.5%
Financing Cash Flow	$-401.0M	↓ 32.26%

	FY19	Y/Y Change
Operating Cash Flow	$1.2B	↑ 3.58%
Investing Cash Flow	$-411.0M	↓ 48.69%
Financing Cash Flow	$225.0M	↓ 156.11%

	FY20	Y/Y Change
Operating Cash Flow	$2.0B	↑ 61.3%
Investing Cash Flow	$-772.0M	↑ 87.83%
Financing Cash Flow	$-1.3B	↓ 663.11%

	FY21	Y/Y Change
Operating Cash Flow	$2.2B	↑ 11.37%
Investing Cash Flow	$21.0M	↓ 102.72%
Financing Cash Flow	$-2.5B	↑ 100.47%

	FY22	Y/Y Change
Operating Cash Flow	$1.7B	↓ 23.06%
Investing Cash Flow	$-543.0M	↓ 2685.71%
Financing Cash Flow	$-1.7B	↓ 31.81%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$444.0M	↑ 372.34%
Investing Cash Flow	$-840.0M	↑ 431.65%
Financing Cash Flow	$189.0M	↓ 348.68%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$207.0M	↓ 53.38%
Investing Cash Flow	$-947.0M	↑ 12.74%
Financing Cash Flow	$-83.0M	↓ 143.92%

Quest Diagnostics Technicals Summary

Sell

Neutral

Buy

Quest Diagnostics is currently in a neutral trading position according to technical analysis indicators.

Quest Diagnostics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Quest Diagnostics Inc.	-5.55%	11.71%	11.51%	-9.41%	44.26%
Idexx Laboratories, Inc.	-0.89%	-16.26%	-25.76%	-36.84%	58.11%
Agilent Technologies Inc.	1.29%	4.05%	-2.66%	-14.26%	60.31%
Thermo Fisher Scientific, Inc.	3.12%	-3.96%	-0.5%	-20.12%	62.74%
Danaher Corp.	-2.46%	-8.35%	-0.91%	-29.52%	50.97%
Iqvia Holdings Inc.	-0.62%	-6.0%	-13.77%	-29.1%	30.33%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Quest Diagnostics Inc.	20.62	20.62	1.78	8.9	0.13	0.06	0.02	60.8
Idexx Laboratories, Inc.	39.84	39.84	4.34	10.73	0.59	0.23	NA	19.72
Agilent Technologies Inc.	30.79	30.79	2.28	5.24	0.25	0.08	0.01	20.53
Thermo Fisher Scientific, Inc.	32.89	32.89	2.0	21.7	0.13	0.05	0.0	128.08
Danaher Corp.	43.32	43.32	3.06	7.5	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	26.28	26.28	1.05	11.11	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Quest Diagnostics Inc.	Hold	$17.1B	44.26%	20.62	8.82%
Idexx Laboratories, Inc.	Buy	$33.8B	58.11%	39.84	22.53%
Agilent Technologies Inc.	Buy	$38.9B	60.31%	30.79	21.75%
Thermo Fisher Scientific, Inc.	Buy	$200.9B	62.74%	32.89	14.48%
Danaher Corp.	Buy	$165.5B	50.97%	43.32	16.39%
Iqvia Holdings Inc.	Buy	$36.3B	30.33%	26.28	9.17%

Quest Diagnostics Dividend announcements

Quest Diagnostics Dividends March, 2025
In the quarter ending March,2025. Quest Diagnostics has declared dividend of $0.75
Read More

About Quest Diagnostics

quest diagnostics (nyse: dgx) empowers people to take action to improve health outcomes. derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. quest annually serves one in three adult americans and half the physicians and hospitals in the united states, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. the company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (ap) services, & interpretive consultation through its medical & scientific staff of about 900 m.d.s & ph.d.s. the company reported 2014 revenues of $7.4 billion. quest diagnostics offers the most extensive clinical testing network in the u.s., with laborator

Organization	Quest Diagnostics
Employees	50000
CEO	Mr. James E. Davis
Industry	Health Services

Management People of Quest Diagnostics

Name	Title
Mr. James E. Davis	Chairman, CEO & President
Mr. Sam A. Samad	Executive VP & CFO
Mr. Michael E. Prevoznik J.D.	Senior VP & General Counsel
Ms. Catherine T. Doherty	Executive Vice President of Regional Businesses
Mr. Karthik Kuppusamy Ph.D.	Senior Vice President of Clinical Solutions
Mr. Michael J. Deppe	Senior VP, Corporate Controller & Chief Accounting Officer
Mr. Murali Balakumar	Senior VP, Chief Information & Digital Officer
Mr. Shawn C. Bevec	Vice President of Investor Relations
Ms. Kristin Lee Wallace Esq.	Senior VP & Chief Compliance Officer
Mr. Gary D. Samuels	Senior VP & Chief Communications Officer

Important FAQs about investing in Quest Diagnostics from India :

What is Quest Diagnostics share price today?

Quest Diagnostics share price today stands at $153.42, Open: $152.47 ; Previous Close: $152.94 ; High: $153.42 ; Low: $152.14 ; 52 Week High: $165.32 ; 52 Week Low: $123.04. The stock opens at $152.47, after a previous close of $152.94. The stock reached a daily high of $153.42 and a low of $152.14, with a 52-week high of $165.32 and a 52-week low of $123.04.

Can Indians buy Quest Diagnostics shares?

Yes, Indians can invest in the Quest Diagnostics (DGX) from India.

With INDmoney, you can buy Quest Diagnostics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Quest Diagnostics at zero transaction cost.

How can I buy Quest Diagnostics shares from India?

It is very easy to buy Quest Diagnostics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Quest Diagnostics be purchased?

Yes, you can buy fractional shares of Quest Diagnostics with INDmoney app.

What are the documents required to start investing in Quest Diagnostics stocks?

To start investing in Quest Diagnostics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.